Phase
Condition
Neoplasms
Neuroblastoma
Treatment
Meaning Centered Psychotherapy for Latinos for Waitlist Control Patients
Functional Assessment of Cancer Therapy - Spiritual Well-Being Scale
Pre-assessment questionnaire
Clinical Study ID
Ages > 18 All Genders Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Phase I: Quantitative
Diagnosed with stages III or IV solid tumor cancer *(as per self report for ICCANpatients)
Age 18 or older
As per self report, Latino/a or Hispanic ethnicity
As per self report, fluent in oral Spanish (monolingual) or fluent in oral Spanishand English (bilingual)
Phase 2: Qualitative
Enrolled in the quantitative phase of study (as seen above)
Completes the quantitative phase questionnaire package
Scores above or below the threshold for the Distress Thermometer (DT≥4 or ≤3)
In the judgment of the investigator, willing and able to be interviewed in Spanishonly
Agrees to be audio- recorded
Phase 3: Provider Feedback
Professionals working in the mental health field;
Have a caseload of five or more Latino cancer patients per month
Able to communicate and read in Spanish
Agrees to be audio or video-recorded
Phase 4: Patient Feedback
Diagnosed with stages III or IV solid tumor cancer *(as per self report for ICCANpatients)
Age 18 or older
As per self report, Latino/a or Hispanic ethnicity
In the judgment of the investigator, willing and able to be interviewed in Spanishonly
Agrees to be audio-recorded
Exclusion
Exclusion Criteria:
Phase 1: Quantitative
In the judgment of the treating physician and/or the consenting professional,presence of significant cognitive impairment (i.e., delirium or dementia) sufficientto preclude meaningful informed consent and/or data collection
In the judgment of the consenting professional, significant or major disablingmedical or psychiatric condition sufficient to preclude meaningful informed consent,interview, or completion of assessment measures (patients whose psychiatric disorderis well controlled by treatment will be eligible)
Phase 2: Qualitative
In the judgment of the treating physician and/or the consenting professional,presence of significant cognitive impairment (i.e., delirium or dementia) sufficientto preclude meaningful informed consent and/or data collection
In the judgment of the consenting professional, significant or major disablingmedical or psychiatric condition sufficient to preclude meaningful informed consent,interview, or completion of assessment measures (patients whose psychiatric disorderis well controlled by treatment will be eligible)
Phase 4: Patient Feedback
Diagnosed with a major disabling medical or psychiatric condition
Unable to understand the consent procedure
Too ill to participate, all as reported by the patient and/or determined by theinvestigator's judgment.
Study Design
Study Description
Connect with a study center
Ponce Health Sciences University
Ponce, 00732
Puerto RicoActive - Recruiting
Lincoln Medical and Mental Health Center
Bronx, New York
United StatesActive - Recruiting
Memorial Sloan Kettering Cancer Center
New York, New York 10065
United StatesActive - Recruiting
Ralph Lauren Center for Cancer Care and Prevention
New York, New York
United StatesActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.